NASDAQ:NTRA

Natera Stock Insider Trading

Healthcare > Medical - Diagnostics & Research

Buy NTRA

*Your capital is at risk

$318.35

-3.75 (-1.16%)

At Close: Aug 10, 2026

Natera Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -98.29. In total, the insiders bought 11.98K and sold 115.08K NTRA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-98.29
● Buy	11.98K shares
● Sell	115.08K shares
14% Buy Activity Negligible or No Correlation
Sell Signal High Confidence Jan 20, 2026 Analysis Breakdown: Strongly supported by a very low Insider Power Score of -98.29. Confidence increased due to high data reliability score of 100. Supported by overwhelming sell-side pressure (14% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Jul 01, 2026 Sell	Common Stock S-Sale	Rabinowitz Daniel Sec. And Chief Legal Officer	Officer	300 Value: $83.6K
Jul 01, 2026 Sell	Common Stock S-Sale	Rabinowitz Daniel Sec. And Chief Legal Officer	Officer	454 Value: $123.6K
Jul 01, 2026 Sell	Common Stock S-Sale	Moshkevich Solomon President, Clinicaldiagnostics	CEO / President	300 Value: $82.2K
Jun 26, 2026 Buy	Common Stock A-Award	Bertagnolli Monica Director	Director	75 Value: $19.6K
Jun 26, 2026 Buy	Common Stock A-Award	Bertagnolli Monica Director	Director	1 571 Value: $411.5K
Jun 26, 2026 Buy	Common Stock A-Award	Baynes Roy D. Director	Director	75 Value: $19.6K
Jun 26, 2026 Buy	Common Stock A-Award	Baynes Roy D. Director	Director	1 571 Value: $411.5K
Jun 26, 2026 Buy	Common Stock A-Award	Rubin Eric H Director	Director	75 Value: $19.6K
Jun 26, 2026 Buy	Common Stock A-Award	Botha Roelof Director	Director	120 Value: $31.4K
Jun 26, 2026 Buy	Common Stock A-Award	Botha Roelof Director	Director	1 571 Value: $411.5K
Jun 26, 2026 Buy	Common Stock A-Award	Rosenman Herm Director	Director	106 Value: $27.8K
Jun 26, 2026 Buy	Common Stock A-Award	Rosenman Herm Director	Director	1 571 Value: $411.5K
Jun 26, 2026 Buy	Common Stock A-Award	Marcus Gail Boxer Director	Director	98 Value: $25.7K
Jun 26, 2026 Buy	Common Stock A-Award	Marcus Gail Boxer Director	Director	1 571 Value: $411.5K
Jun 26, 2026 Buy	Common Stock A-Award	Lynch Thomas J. Jr. Director	Director	1 905 Value: $498.9K
Jun 26, 2026 Buy	Common Stock A-Award	Chapman Rowan E Director	Director	103 Value: $27.0K
Jun 26, 2026 Buy	Common Stock A-Award	Chapman Rowan E Director	Director	1 571 Value: $411.5K
Jun 24, 2026 Sell	Common Stock S-Sale	Rabinowitz Daniel Sec. And Chief Legal Officer	Officer	16 204 Value: $4.06M
Jun 24, 2026 Sell	Common Stock S-Sale	Rosenman Herm Director	Director	16 530 Value: $4.13M
Jun 24, 2026 Sell	Common Stock S-Sale	Rabinowitz Daniel Sec. And Chief Legal Officer	Officer	1 200 Value: $301.9K
Jun 24, 2026 Sell	Common Stock S-Sale	Rabinowitz Daniel Sec. And Chief Legal Officer	Officer	5 066 Value: $1.28M
Jun 24, 2026 Sell	Common Stock S-Sale	Rabinowitz Daniel Sec. And Chief Legal Officer	Officer	11 130 Value: $2.82M
Jun 17, 2026 Sell	Common Stock S-Sale	Sheena Jonathan Co-founder	Director	267 Value: $58.3K
Jun 17, 2026 Sell	Common Stock S-Sale	Sheena Jonathan Co-founder	Director	256 Value: $55.8K
Jun 17, 2026 Sell	Common Stock S-Sale	Sheena Jonathan Co-founder	Director	96 Value: $21.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT NATERA

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases; a...

Read Full Profile Here